The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tessari Eben since 2022.
This trader's CIK number is 1867899.
At the time of last reporting, Tessari Eben was the CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals International, Plc. (stock ticker symbol KNSA).
Also see all insider trading activities at Kiniksa Pharmaceuticals International, Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KNSA | 0 | $0 | 327,381 | $10,015,119 | 288,490 | $2,831,462 |
| 2024 | KNSA | 0 | $0 | 93,206 | $2,219,380 | 65,862 | $90,110 |
| 2023 | KNSA | 0 | $0 | 0 | $0 | 12,364 | $0 |
| 2022 | KNSA | 0 | $0 | 0 | $0 | 6,575 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | KNSA | Sale | 15,091 | 35.50 | 535,730 |
| 2025-09-01 | KNSA | Option Ex | 6,245 | .00 | 0 |
| 2025-09-02 | KNSA | Option Ex | 1,964 | .00 | 0 |
| 2025-09-03 | KNSA | Option Ex | 15,091 | 15.51 | 234,061 |
| 2025-08-18 | KNSA | Sale | 16,200 | 34.10 | 552,501 |
| 2025-08-18 | KNSA | Option Ex | 6,500 | 8.83 | 57,395 |
| 2025-08-05 | KNSA | Sale | 138,614 | 33.55 | 4,650,499 |
| 2025-08-05 | KNSA | Option Ex | 138,614 | 11.43 | 1,584,635 |
| 2025-07-14 | KNSA | Option Ex | 6,500 | 8.83 | 57,395 |
| 2025-07-14 | KNSA | Sale | 18,900 | 28.72 | 542,808 |
| 2025-06-16 | KNSA | Option Ex | 6,500 | 8.83 | 57,395 |
| 2025-06-16 | KNSA | Sale | 17,300 | 28.28 | 489,244 |
| 2025-06-11 | KNSA | Sale | 45,042 | 30.51 | 1,374,231 |
| 2025-06-10 | KNSA | Sale | 15,506 | 30.46 | 472,312 |
| 2025-06-09 | KNSA | Sale | 10,319 | 30.38 | 313,491 |
| 2025-06-11 | KNSA | Option Ex | 45,042 | 10.36 | 466,635 |
| 2025-06-10 | KNSA | Option Ex | 15,506 | 10.36 | 160,642 |
| 2025-06-09 | KNSA | Option Ex | 10,319 | 10.36 | 106,904 |
| 2025-05-19 | KNSA | Option Ex | 7,000 | 3.80 | 26,600 |
| 2025-05-19 | KNSA | Sale | 12,000 | 26.41 | 316,920 |
| 2025-04-14 | KNSA | Sale | 12,000 | 20.46 | 245,580 |
| 2025-04-14 | KNSA | Option Ex | 7,000 | 3.80 | 26,600 |
| 2025-04-07 | KNSA | Option Ex | 2,726 | .00 | 0 |
| 2025-04-01 | KNSA | Option Ex | 3,519 | .00 | 0 |
| 2025-03-16 | KNSA | Option Ex | 1,964 | .00 | 0 |
| 2025-03-10 | KNSA | Option Ex | 7,000 | 3.80 | 26,600 |
| 2025-03-10 | KNSA | Sale | 12,409 | 21.06 | 261,333 |
| 2025-01-13 | KNSA | Option Ex | 7,000 | 3.80 | 26,600 |
| 2025-01-13 | KNSA | Sale | 14,000 | 18.61 | 260,470 |
| 2024-12-16 | KNSA | Option Ex | 16,017 | 1.59 | 25,467 |
| 2024-12-16 | KNSA | Sale | 23,017 | 20.44 | 470,467 |
| 2024-11-18 | KNSA | Sale | 17,000 | 21.04 | 357,680 |
| 2024-11-18 | KNSA | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-10-15 | KNSA | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-10-15 | KNSA | Sale | 17,000 | 26.87 | 456,790 |
| 2024-09-23 | KNSA | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-09-23 | KNSA | Sale | 17,500 | 24.99 | 437,325 |
| 2024-09-02 | KNSA | Option Ex | 1,964 | .00 | 0 |
| 2024-09-01 | KNSA | Option Ex | 4,499 | .00 | 0 |
| 2024-08-27 | KNSA | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-08-27 | KNSA | Sale | 17,500 | 26.91 | 470,925 |
| 2024-04-08 | KNSA | Option Ex | 2,726 | .00 | 0 |
| 2024-03-01 | KNSA | Option Ex | 656 | 1.59 | 1,043 |
| 2024-03-01 | KNSA | Sale | 1,189 | 22.03 | 26,193 |
| 2023-09-02 | KNSA | Option Ex | 1,964 | .00 | 0 |
| 2023-09-01 | KNSA | Option Ex | 2,727 | .00 | 0 |
| 2023-04-10 | KNSA | Option Ex | 2,727 | .00 | 0 |
| 2023-03-20 | KNSA | Option Ex | 2,982 | .00 | 0 |
| 2023-03-16 | KNSA | Option Ex | 1,964 | .00 | 0 |
| 2022-03-21 | KNSA | Option Ex | 4,611 | .00 | 0 |
| 2022-03-16 | KNSA | Option Ex | 1,964 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tessari Eben (CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals International, Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.